EMEA (Europe, Middle East and Africa) Antibacterial Drug Resistance Market Report 2017

November 2017 | 121 pages | ID: EB87B946290EN
QYResearch

Abstracts

In this report, the EMEA Antibacterial Drug Resistance market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Antibacterial Drug Resistance for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Antibacterial Drug Resistance market competition by top manufacturers/players, with Antibacterial Drug Resistance sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• AAIPharma Services
• ANTABIO
• Abgentis
• Abbott Laboratories
• Absynth Biologics
• Achaogen
• Acino Holdings
• Aventis Pharma
• Austell Laboratories
• Assembly Biosciences
• Arpida
• Demuris
• Evolva Holding
• ContraFect
• Cerexa
• GSK
• InterMune
• Isis Pharmaceuticals
• Lyndra
• Microbecide
• Morphochem
• Nabriva Therapeutics
• NanoSafe Coatings
• Novexel
• Osel
• PENDOPHARM
• Pfizer
• VenatoRx Pharmaceuticals

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Telavancin (Vibativ)
• Ceftaroline Fosamil (Teflaro/ Zinforo)
• Fidaxomicin (Dificid / Dificlir)
• Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)
• Dalbavancin (Dalvance/ Xydalba)
• Tedizolid Phosphate (Sivextro)
• Oritavancin (Orbactiv/ Nuvocid)
• Ceftolozane-Tazobactam (Zerbaxa)
• Ceftazidime-Avibactam (Avycaz/ Zavicefta)
• PHASE III DRUGS

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Antibacterial Drug Resistance for each application, including

• Gram-Positive
• Gram-Negative

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Antibacterial Drug Resistance Market Report 2017

1 ANTIBACTERIAL DRUG RESISTANCE OVERVIEW

1.1 Product Overview and Scope of Antibacterial Drug Resistance
1.2 Classification of Antibacterial Drug Resistance
  1.2.1 EMEA Antibacterial Drug Resistance Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Antibacterial Drug Resistance Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Telavancin (Vibativ)
  1.2.4 Ceftaroline Fosamil (Teflaro/ Zinforo)
  1.2.5 Fidaxomicin (Dificid / Dificlir)
  1.2.6 Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)
  1.2.7 Dalbavancin (Dalvance/ Xydalba)
  1.2.8 Tedizolid Phosphate (Sivextro)
  1.2.9 Oritavancin (Orbactiv/ Nuvocid)
  1.2.10 Ceftolozane-Tazobactam (Zerbaxa)
  1.2.11 Ceftazidime-Avibactam (Avycaz/ Zavicefta)
  1.2.12 PHASE III DRUGS
1.3 EMEA Antibacterial Drug Resistance Market by Application/End Users
  1.3.1 EMEA Antibacterial Drug Resistance Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Gram-Positive
  1.3.3 Gram-Negative
1.4 EMEA Antibacterial Drug Resistance Market by Region
  1.4.1 EMEA Antibacterial Drug Resistance Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Antibacterial Drug Resistance (2012-2022)
  1.5.1 EMEA Antibacterial Drug Resistance Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Antibacterial Drug Resistance Revenue and Growth Rate (2012-2022)

2 EMEA ANTIBACTERIAL DRUG RESISTANCE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Antibacterial Drug Resistance Market Competition by Players/Manufacturers
  2.1.1 EMEA Antibacterial Drug Resistance Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Antibacterial Drug Resistance Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Antibacterial Drug Resistance Sale Price by Players (2012-2017)
2.2 EMEA Antibacterial Drug Resistance (Volume and Value) by Type/Product Category
  2.2.1 EMEA Antibacterial Drug Resistance Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Antibacterial Drug Resistance Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Antibacterial Drug Resistance Sale Price by Type (2012-2017)
2.3 EMEA Antibacterial Drug Resistance (Volume) by Application
2.4 EMEA Antibacterial Drug Resistance (Volume and Value) by Region
  2.4.1 EMEA Antibacterial Drug Resistance Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Antibacterial Drug Resistance Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Antibacterial Drug Resistance Sales Price by Region (2012-2017)

3 EUROPE ANTIBACTERIAL DRUG RESISTANCE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Antibacterial Drug Resistance Sales and Value (2012-2017)
  3.1.1 Europe Antibacterial Drug Resistance Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
3.2 Europe Antibacterial Drug Resistance Sales and Market Share by Type
3.3 Europe Antibacterial Drug Resistance Sales and Market Share by Application
3.4 Europe Antibacterial Drug Resistance Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Antibacterial Drug Resistance Sales Volume by Countries (2012-2017)
  3.4.2 Europe Antibacterial Drug Resistance Revenue by Countries (2012-2017)
  3.4.3 Germany Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
  3.4.4 France Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
  3.4.5 UK Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
  3.4.6 Russia Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
  3.4.7 Italy Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ANTIBACTERIAL DRUG RESISTANCE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Antibacterial Drug Resistance Sales and Value (2012-2017)
  4.1.1 Middle East Antibacterial Drug Resistance Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
4.2 Middle East Antibacterial Drug Resistance Sales and Market Share by Type
4.3 Middle East Antibacterial Drug Resistance Sales and Market Share by Application
4.4 Middle East Antibacterial Drug Resistance Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Antibacterial Drug Resistance Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Antibacterial Drug Resistance Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
  4.4.4 Israel Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
  4.4.5 UAE Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
  4.4.6 Iran Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)

5 AFRICA ANTIBACTERIAL DRUG RESISTANCE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Antibacterial Drug Resistance Sales and Value (2012-2017)
  5.1.1 Africa Antibacterial Drug Resistance Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
5.2 Africa Antibacterial Drug Resistance Sales and Market Share by Type
5.3 Africa Antibacterial Drug Resistance Sales and Market Share by Application
5.4 Africa Antibacterial Drug Resistance Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Antibacterial Drug Resistance Sales Volume by Countries (2012-2017)
  5.4.2 Africa Antibacterial Drug Resistance Revenue by Countries (2012-2017)
  5.4.3 South Africa Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Antibacterial Drug Resistance Sales and Growth Rate (2012-2017)

6 EMEA ANTIBACTERIAL DRUG RESISTANCE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 AAIPharma Services
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antibacterial Drug Resistance Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AAIPharma Services Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 ANTABIO
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Antibacterial Drug Resistance Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 ANTABIO Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Abgentis
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Antibacterial Drug Resistance Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Abgentis Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Abbott Laboratories
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Antibacterial Drug Resistance Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Abbott Laboratories Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Absynth Biologics
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Antibacterial Drug Resistance Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Absynth Biologics Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Achaogen
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Antibacterial Drug Resistance Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Achaogen Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Acino Holdings
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Antibacterial Drug Resistance Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Acino Holdings Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Aventis Pharma
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Antibacterial Drug Resistance Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Aventis Pharma Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Austell Laboratories
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Antibacterial Drug Resistance Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Austell Laboratories Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Assembly Biosciences
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Antibacterial Drug Resistance Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Assembly Biosciences Antibacterial Drug Resistance Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Arpida
6.12 Demuris
6.13 Evolva Holding
6.14 ContraFect
6.15 Cerexa
6.16 GSK
6.17 InterMune
6.18 Isis Pharmaceuticals
6.19 Lyndra
6.20 Microbecide
6.21 Morphochem
6.22 Nabriva Therapeutics
6.23 NanoSafe Coatings
6.24 Novexel
6.25 Osel
6.26 PENDOPHARM
6.27 Pfizer
6.28 VenatoRx Pharmaceuticals

7 ANTIBACTERIAL DRUG RESISTANCE MANUFACTURING COST ANALYSIS

7.1 Antibacterial Drug Resistance Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antibacterial Drug Resistance

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antibacterial Drug Resistance Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antibacterial Drug Resistance Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ANTIBACTERIAL DRUG RESISTANCE MARKET FORECAST (2017-2022)

11.1 EMEA Antibacterial Drug Resistance Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Antibacterial Drug Resistance Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Antibacterial Drug Resistance Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Antibacterial Drug Resistance Price and Trend Forecast (2017-2022)
11.2 EMEA Antibacterial Drug Resistance Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Antibacterial Drug Resistance Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Antibacterial Drug Resistance Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Antibacterial Drug Resistance Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Antibacterial Drug Resistance Sales Forecast by Type (2017-2022)
11.7 EMEA Antibacterial Drug Resistance Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Antibacterial Drug Resistance
Figure EMEA Antibacterial Drug Resistance Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Antibacterial Drug Resistance Sales Volume Market Share by Type (Product Category) in 2016
Figure Telavancin (Vibativ) Product Picture
Figure Ceftaroline Fosamil (Teflaro/ Zinforo) Product Picture
Figure Fidaxomicin (Dificid / Dificlir) Product Picture
Figure Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio) Product Picture
Figure Dalbavancin (Dalvance/ Xydalba) Product Picture
Figure Tedizolid Phosphate (Sivextro) Product Picture
Figure Oritavancin (Orbactiv/ Nuvocid) Product Picture
Figure Ceftolozane-Tazobactam (Zerbaxa) Product Picture
Figure Ceftazidime-Avibactam (Avycaz/ Zavicefta) Product Picture
Figure PHASE III DRUGS Product Picture
Figure EMEA Antibacterial Drug Resistance Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Antibacterial Drug Resistance by Application in 2016
Figure Gram-Positive Examples
Figure Gram-Negative Examples
Figure EMEA Antibacterial Drug Resistance Market Size (Million USD) by Region (2012-2022)
Figure Europe Antibacterial Drug Resistance Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Antibacterial Drug Resistance Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Antibacterial Drug Resistance Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Antibacterial Drug Resistance Revenue (Million USD) Status and Forecast by Countries
Figure Africa Antibacterial Drug Resistance Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Antibacterial Drug Resistance Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Antibacterial Drug Resistance Sales Volume and Growth Rate (2012-2022)
Figure EMEA Antibacterial Drug Resistance Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Antibacterial Drug Resistance Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Antibacterial Drug Resistance Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Antibacterial Drug Resistance Sales Share by Players (2012-2017)
Figure 2016 Antibacterial Drug Resistance Sales Share by Players
Figure 2017 Antibacterial Drug Resistance Sales Share by Players
Figure EMEA Antibacterial Drug Resistance Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Antibacterial Drug Resistance Revenue (Million USD) by Players (2012-2017)
Table EMEA Antibacterial Drug Resistance Revenue Share by Players (2012-2017)
Table 2016 EMEA Antibacterial Drug Resistance Revenue Share by Players
Table 2017 EMEA Antibacterial Drug Resistance Revenue Share by Players
Table EMEA Antibacterial Drug Resistance Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Antibacterial Drug Resistance Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Antibacterial Drug Resistance Sales Share by Type (2012-2017)
Figure Sales Market Share of Antibacterial Drug Resistance by Type (2012-2017)
Figure EMEA Antibacterial Drug Resistance Sales Market Share by Type (2012-2017)
Table EMEA Antibacterial Drug Resistance Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Antibacterial Drug Resistance Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antibacterial Drug Resistance by Type in 2016
Table EMEA Antibacterial Drug Resistance Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Antibacterial Drug Resistance Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Antibacterial Drug Resistance Sales Share by Application (2012-2017)
Figure Sales Market Share of Antibacterial Drug Resistance by Application (2012-2017)
Figure EMEA Antibacterial Drug Resistance Sales Market Share by Application in 2016
Table EMEA Antibacterial Drug Resistance Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Antibacterial Drug Resistance Sales Share by Region (2012-2017)
Figure Sales Market Share of Antibacterial Drug Resistance by Region (2012-2017)
Figure EMEA Antibacterial Drug Resistance Sales Market Share in 2016
Table EMEA Antibacterial Drug Resistance Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Antibacterial Drug Resistance Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Antibacterial Drug Resistance by Region (2012-2017)
Figure EMEA Antibacterial Drug Resistance Revenue Market Share Regions in 2016
Table EMEA Antibacterial Drug Resistance Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Antibacterial Drug Resistance Revenue and Growth Rate (2012-2017)
Table Europe Antibacterial Drug Resistance Sales (K Units) by Type (2012-2017)
Table Europe Antibacterial Drug Resistance Market Share by Type (2012-2017)
Figure Europe Antibacterial Drug Resistance Market Share by Type in 2016
Table Europe Antibacterial Drug Resistance Sales (K Units) by Application (2012-2017)
Table Europe Antibacterial Drug Resistance Market Share by Application (2012-2017)
Figure Europe Antibacterial Drug Resistance Market Share by Application in 2016
Table Europe Antibacterial Drug Resistance Sales (K Units) by Countries (2012-2017)
Table Europe Antibacterial Drug Resistance Sales Market Share by Countries (2012-2017)
Figure Europe Antibacterial Drug Resistance Sales Market Share by Countries (2012-2017)
Figure Europe Antibacterial Drug Resistance Sales Market Share by Countries in 2016
Table Europe Antibacterial Drug Resistance Revenue (Million USD) by Countries (2012-2017)
Table Europe Antibacterial Drug Resistance Revenue Market Share by Countries (2012-2017)
Figure Europe Antibacterial Drug Resistance Revenue Market Share by Countries (2012-2017)
Figure Europe Antibacterial Drug Resistance Revenue Market Share by Countries in 2016
Figure Germany Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure France Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure UK Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Antibacterial Drug Resistance Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Antibacterial Drug Resistance Sales (K Units) by Type (2012-2017)
Table Middle East Antibacterial Drug Resistance Market Share by Type (2012-2017)
Figure Middle East Antibacterial Drug Resistance Market Share by Type (2012-2017)
Table Middle East Antibacterial Drug Resistance Sales (K Units) by Applications (2012-2017)
Table Middle East Antibacterial Drug Resistance Market Share by Applications (2012-2017)
Figure Middle East Antibacterial Drug Resistance Sales Market Share by Application in 2016
Table Middle East Antibacterial Drug Resistance Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Antibacterial Drug Resistance Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Antibacterial Drug Resistance Sales Volume Market Share by Countries in 2016
Table Middle East Antibacterial Drug Resistance Revenue (Million USD) by Countries (2012-2017)
Table Middle East Antibacterial Drug Resistance Revenue Market Share by Countries (2012-2017)
Figure Middle East Antibacterial Drug Resistance Revenue Market Share by Countries (2012-2017)
Figure Middle East Antibacterial Drug Resistance Revenue Market Share by Countries in 2016
Figure Saudi Arabia Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Antibacterial Drug Resistance Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Antibacterial Drug Resistance Sales (K Units) by Type (2012-2017)
Table Africa Antibacterial Drug Resistance Sales Market Share by Type (2012-2017)
Figure Africa Antibacterial Drug Resistance Sales Market Share by Type (2012-2017)
Figure Africa Antibacterial Drug Resistance Sales Market Share by Type in 2016
Table Africa Antibacterial Drug Resistance Sales (K Units) by Application (2012-2017)
Table Africa Antibacterial Drug Resistance Sales Market Share by Application (2012-2017)
Figure Africa Antibacterial Drug Resistance Sales Market Share by Application (2012-2017)
Table Africa Antibacterial Drug Resistance Sales Volume (K Units) by Countries (2012-2017)
Table Africa Antibacterial Drug Resistance Sales Market Share by Countries (2012-2017)
Figure Africa Antibacterial Drug Resistance Sales Market Share by Countries (2012-2017)
Figure Africa Antibacterial Drug Resistance Sales Market Share by Countries in 2016
Table Africa Antibacterial Drug Resistance Revenue (Million USD) by Countries (2012-2017)
Table Africa Antibacterial Drug Resistance Revenue Market Share by Countries (2012-2017)
Figure Africa Antibacterial Drug Resistance Revenue Market Share by Countries (2012-2017)
Figure Africa Antibacterial Drug Resistance Revenue Market Share by Countries in 2016
Figure South Africa Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Table AAIPharma Services Antibacterial Drug Resistance Basic Information List
Table AAIPharma Services Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AAIPharma Services Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure AAIPharma Services Antibacterial Drug Resistance Sales Market Share in EMEA (2012-2017)
Figure AAIPharma Services Antibacterial Drug Resistance Revenue Market Share in EMEA (2012-2017)
Table ANTABIO Antibacterial Drug Resistance Basic Information List
Table ANTABIO Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ANTABIO Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure ANTABIO Antibacterial Drug Resistance Sales Market Share in EMEA (2012-2017)
Figure ANTABIO Antibacterial Drug Resistance Revenue Market Share in EMEA (2012-2017)
Table Abgentis Antibacterial Drug Resistance Basic Information List
Table Abgentis Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abgentis Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure Abgentis Antibacterial Drug Resistance Sales Market Share in EMEA (2012-2017)
Figure Abgentis Antibacterial Drug Resistance Revenue Market Share in EMEA (2012-2017)
Table Abbott Laboratories Antibacterial Drug Resistance Basic Information List
Table Abbott Laboratories Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure Abbott Laboratories Antibacterial Drug Resistance Sales Market Share in EMEA (2012-2017)
Figure Abbott Laboratories Antibacterial Drug Resistance Revenue Market Share in EMEA (2012-2017)
Table Absynth Biologics Antibacterial Drug Resistance Basic Information List
Table Absynth Biologics Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Absynth Biologics Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure Absynth Biologics Antibacterial Drug Resistance Sales Market Share in EMEA (2012-2017)
Figure Absynth Biologics Antibacterial Drug Resistance Revenue Market Share in EMEA (2012-2017)
Table Achaogen Antibacterial Drug Resistance Basic Information List
Table Achaogen Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Achaogen Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure Achaogen Antibacterial Drug Resistance Sales Market Share in EMEA (2012-2017)
Figure Achaogen Antibacterial Drug Resistance Revenue Market Share in EMEA (2012-2017)
Table Acino Holdings Antibacterial Drug Resistance Basic Information List
Table Acino Holdings Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Acino Holdings Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure Acino Holdings Antibacterial Drug Resistance Sales Market Share in EMEA (2012-2017)
Figure Acino Holdings Antibacterial Drug Resistance Revenue Market Share in EMEA (2012-2017)
Table Aventis Pharma Antibacterial Drug Resistance Basic Information List
Table Aventis Pharma Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Aventis Pharma Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure Aventis Pharma Antibacterial Drug Resistance Sales Market Share in EMEA (2012-2017)
Figure Aventis Pharma Antibacterial Drug Resistance Revenue Market Share in EMEA (2012-2017)
Table Austell Laboratories Antibacterial Drug Resistance Basic Information List
Table Austell Laboratories Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Austell Laboratories Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure Austell Laboratories Antibacterial Drug Resistance Sales Market Share in EMEA (2012-2017)
Figure Austell Laboratories Antibacterial Drug Resistance Revenue Market Share in EMEA (2012-2017)
Table Assembly Biosciences Antibacterial Drug Resistance Basic Information List
Table Assembly Biosciences Antibacterial Drug Resistance Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Assembly Biosciences Antibacterial Drug Resistance Sales (K Units) and Growth Rate (2012-2017)
Figure Assembly Biosciences Antibacterial Drug Resistance Sales Market Share in EMEA (2012-2017)
Figure Assembly Biosciences Antibacterial Drug Resistance Revenue Market Share in EMEA (2012-2017)
Table Arpida Antibacterial Drug Resistance Basic Information List
Table Demuris Antibacterial Drug Resistance Basic Information List
Table Evolva Holding Antibacterial Drug Resistance Basic Information List
Table ContraFect Antibacterial Drug Resistance Basic Information List
Table Cerexa Antibacterial Drug Resistance Basic Information List
Table GSK Antibacterial Drug Resistance Basic Information List
Table InterMune Antibacterial Drug Resistance Basic Information List
Table Isis Pharmaceuticals Antibacterial Drug Resistance Basic Information List
Table Lyndra Antibacterial Drug Resistance Basic Information List
Table Microbecide Antibacterial Drug Resistance Basic Information List
Table Morphochem Antibacterial Drug Resistance Basic Information List
Table Nabriva Therapeutics Antibacterial Drug Resistance Basic Information List
Table NanoSafe Coatings Antibacterial Drug Resistance Basic Information List
Table Novexel Antibacterial Drug Resistance Basic Information List
Table Osel Antibacterial Drug Resistance Basic Information List
Table PENDOPHARM Antibacterial Drug Resistance Basic Information List
Table Pfizer Antibacterial Drug Resistance Basic Information List
Table VenatoRx Pharmaceuticals Antibacterial Drug Resistance Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibacterial Drug Resistance
Figure Manufacturing Process Analysis of Antibacterial Drug Resistance
Figure Antibacterial Drug Resistance Industrial Chain Analysis
Table Raw Materials Sources of Antibacterial Drug Resistance Major Manufacturers in 2016
Table Major Buyers of Antibacterial Drug Resistance
Table Distributors/Traders List
Figure EMEA Antibacterial Drug Resistance Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Antibacterial Drug Resistance Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Antibacterial Drug Resistance Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Antibacterial Drug Resistance Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Antibacterial Drug Resistance Sales Market Share Forecast by Region (2017-2022)
Table EMEA Antibacterial Drug Resistance Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Antibacterial Drug Resistance Revenue Market Share Forecast by Region (2017-2022)
Table Europe Antibacterial Drug Resistance Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Antibacterial Drug Resistance Sales Market Share Forecast by Countries (2017-2022)
Table Europe Antibacterial Drug Resistance Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Antibacterial Drug Resistance Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Antibacterial Drug Resistance Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Antibacterial Drug Resistance Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Antibacterial Drug Resistance Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Antibacterial Drug Resistance Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Antibacterial Drug Resistance Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Antibacterial Drug Resistance Sales Market Share Forecast by Countries (2017-2022)
Table Africa Antibacterial Drug Resistance Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Antibacterial Drug Resistance Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Antibacterial Drug Resistance Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Antibacterial Drug Resistance Sales Market Share Forecast by Type (2017-2022)
Table EMEA Antibacterial Drug Resistance Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Antibacterial Drug Resistance Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources